ArticleCancer biology & therapy2017

Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancer.

Avital Lev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.